Validation of Claims‐Based Algorithms for Identifying Congenital Urinary Tract, Genital, Gastrointestinal, and Musculoskeletal Malformations
Pharmacoepidemiology and Drug Safety · 2026-09 · 35 (9)
DOI: 10.1002/pds.70461 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 19.08.2026. Verfasst von Kelly Fung und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass…. Hauptthemen laut MEDLINE: Algorithms, Urogenital Abnormalities, Musculoskeletal Abnormalities, Abnormalities, Drug-Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD NIH HHS, the National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Aim
Congenital malformations are important outcomes when evaluating medication safety in pregnancy. However, the accuracy of claims‐based algorithms for identifying organ‐specific malformations remains understudied. We validated algorithms for four malformation groups: urinary tract, genital, gastrointestinal, and musculoskeletal. Materials and Methods Using the Mass General Brigham (MGB, 2007–2020) and Stanford Medicine (2016–2023) databases, we identified infants with potential malformations of interest based on diagnosis and procedure codes within 90 days of birth. A total of 150 cases were sampled for each malformation group. Positive predictive values (PPV) were estimated to quantify the validity of the algorithms, separately by site and by International Classification of Diseases (ICD) coding system.
Results
For MGB ICD‐9, MGB ICD‐10, and Stanford ICD‐10 algorithms, respectively, PPVs were 100%, 98.0%, and 95.8% for urinary tract malformations; 98.0%, 95.9%, and 93.8% for genital malformations; 76.0%, 78.0%, and 76.0% for gastrointestinal malformations; and 85.4%, 84.0%, and 62.0% for musculoskeletal malformations. False positives were primarily attributed to suspected malformations that were later ruled out and to broader or inaccurate coding for diagnoses that were not major malformations.
Conclusions
Claims‐based algorithms demonstrated high PPVs for urinary tract and genital malformations and moderate for gastrointestinal malformations, but there was variation in musculoskeletal PPVs between the institutions with different patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Division of Maternal-Fetal Medicine and Obstetrics, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California, USA.
- Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA.
- Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
- Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, Washington, USA.
- Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Kelly Fung, Stephanie A Leonard, Krista F Huybrechts, Sonia Hernandez-Diaz, Loreen Straub, Ayesha Sujan, Kathryn J Gray, Amanda E Winkler, Emily Walker Stockert, Yanmin Zhu
Förderung
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NICHD NIH HHS
- the National Institute of Neurological Disorders and Stroke
- NIGMS NIH HHS
- the National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Fung, K., Leonard, S. A., Huybrechts, K. F., Hernandez-Diaz, S., Bateman, B. T., Straub, L., Sujan, A., Gray, K. J., Andersen, K., Chen, E. Y., El-Tayeb, K., Jeancharles, M., Mootz, A. A., Winkler, A. E., Fernando, A. M., Qin, C. X., Stockert, E. W., Mogun, H., & Zhu, Y. (2026). Validation of Claims‐Based Algorithms for Identifying Congenital Urinary Tract, Genital, Gastrointestinal, and Musculoskeletal Malformations. Pharmacoepidemiology and Drug Safety, 35(9). https://doi.org/10.1002/pds.70461
Vancouver
Fung K, Leonard SA, Huybrechts KF, Hernandez-Diaz S, Bateman BT, Straub L, et al. Validation of Claims‐Based Algorithms for Identifying Congenital Urinary Tract, Genital, Gastrointestinal, and Musculoskeletal Malformations. Pharmacoepidemiology and Drug Safety. 2026;35(9). doi:10.1002/pds.70461
BibTeX
@article{Fung2026,
author = {Fung, Kelly and Leonard, Stephanie A and Huybrechts, Krista F and Hernandez-Diaz, Sonia and Bateman, Brian T and Straub, Loreen and Sujan, Ayesha and Gray, Kathryn J and Andersen, Kylie and Chen, Eric Y and El-Tayeb, Kareem and Jeancharles, Murka and Mootz, Allison A and Winkler, Amanda E and Fernando, Amali Maria and Qin, Caroline X and Stockert, Emily Walker and Mogun, Helen and Zhu, Yanmin},
title = {Validation of Claims‐Based Algorithms for Identifying Congenital Urinary Tract, Genital, Gastrointestinal, and Musculoskeletal Malformations},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
volume = {35},
number = {9},
doi = {10.1002/pds.70461}
}
EUVIMED